Browse Pet Safety Reports
16,682 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,682 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,682 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| May 16, 2023 | Human | Unknown | Nitenpyram | Oral bleeding | Recovered/Normal |
| May 15, 2023 | Human | Unknown | Imidacloprid; Moxidectin | Taste alteration; Tingling sensation; Tongue disorder NOS | Ongoing |
| May 15, 2023 | Human | Unknown | Levothyroxine Sodium, Usp | No sign; Accidental exposure | Outcome Unknown |
| May 12, 2023 | Human | Unknown | Neomycin Sulfate; Thiabendazole; Dexa... | Burning sensation of eye; Eye pain; Swollen eye; Epiphora | Outcome Unknown |
| May 12, 2023 | Human | Unknown | Insulin Injectable Vial | Injection site lump; Fainting; Tinnitus; Increased sweating | Ongoing |
| May 11, 2023 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Seal, Abnormal; Tubes, Leaking | Recovered/Normal |
| May 9, 2023 | Human | Unknown | Fluralaner Spot-On Solution | Rash; Closure, Abnormal; Containers, Leaking | Ongoing |
| May 9, 2023 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Medication error | Recovered/Normal |
| May 8, 2023 | Human | Unknown | Nitenpyram | Headache | Recovered/Normal |
| May 6, 2023 | Human | Unknown | Tilmicosin | Nervousness; Feeling anxious | Outcome Unknown |
| May 5, 2023 | Human | Unknown | Frunevetmab | Puncture wound; Injection site pain; Accidental exposure | Outcome Unknown |
| May 4, 2023 | Human | Unknown | Eprinomectin | Injection site pain; Accidental exposure | Outcome Unknown |
| May 3, 2023 | Human | Unknown | Buprenorphine | Nervousness | Outcome Unknown |
| May 3, 2023 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Medication error | Ongoing |
| May 3, 2023 | Human | Unknown | Florfenicol, Terbinafine, Betamethaso... | Vision blurred; Accidental exposure | Recovered/Normal |
| May 3, 2023 | Human | Unknown | Buprenorphine | Eye irritation; Eye redness | Ongoing |
| May 1, 2023 | Human | Unknown | Fluralaner Spot-On Solution | Bad taste; Application site stickiness; Wrong technique in drug usage process... | Recovered/Normal |
| Apr 30, 2023 | Human | Unknown | Selamectin | Skin irritation | Outcome Unknown |
| Apr 27, 2023 | Human | Unknown | Clomipramine Hydrochloride | Feeling anxious; Stomach upset | Outcome Unknown |
| Apr 27, 2023 | Human | Unknown | Selamectin;Sarolaner | No sign; Tubes, Damaged; Tubes, Leaking | Outcome Unknown |
| Apr 27, 2023 | Human | Unknown | Nitenpyram | Tingling sensation | Outcome Unknown |
| Apr 26, 2023 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Medication error; Application site stickiness | Ongoing |
| Apr 26, 2023 | Human | Unknown | Neomycin Sulfate; Thiabendazole; Dexa... | Burning sensation of eye | Recovered/Normal |
| Apr 25, 2023 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness | Ongoing |
| Apr 24, 2023 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Medication error | Recovered/Normal |
| Apr 23, 2023 | Human | Unknown | Selamectin;Sarolaner | No sign; Tubes, Damaged; Underfilling, Tubes; Tubes, Leaking; Caps, Abnormal | Outcome Unknown |
| Apr 21, 2023 | Human | Unknown | Selamectin | Burning mouth sensation | Outcome Unknown |
| Apr 21, 2023 | Human | Unknown | Selamectin | Bad taste; Accidental exposure | Recovered/Normal |
| Apr 21, 2023 | Human | Unknown | Spinosad; Milbemycin Oxime | Malodour | Recovered/Normal |
| Apr 21, 2023 | Human | Unknown | Spinosad; Milbemycin Oxime | Malodour | Recovered/Normal |
| Apr 21, 2023 | Human | Unknown | Copper Naphthenate | Eye irritation | Outcome Unknown |
| Apr 21, 2023 | Human | Unknown | Florfenicol; Mometasone Furoate; Terb... | Eye pain; Accidental exposure | Recovered/Normal |
| Apr 20, 2023 | Human | Unknown | Bacitracin Methylene Disalicylate | Skin irritation | Outcome Unknown |
| Apr 19, 2023 | Human | Unknown | Buprenorphine | Lack of spontaneous speech; Light headedness; Slurred speech | Ongoing |
| Apr 18, 2023 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Medication error; Application site stickiness; Application site tingling; App... | Ongoing |
| Apr 15, 2023 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness | Recovered/Normal |
| Apr 14, 2023 | Human | Unknown | Fluralaner Spot-On Solution | Medication error; Application site stickiness | Ongoing |
| Apr 14, 2023 | Human | Unknown | Nitenpyram | Vision blurred; Headache; Accidental exposure | Recovered/Normal |
| Apr 14, 2023 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness | Recovered/Normal |
| Apr 11, 2023 | Human | Unknown | Fluralaner 13.64% 12-Week Chew | Itching; Rash | Recovered/Normal |
| Apr 11, 2023 | Human | Unknown | Ceftiofur Crystalline Free Acid | Respiratory signs; Pulmonary congestion; Irritability; Accidental drug intake... | Outcome Unknown |
| Apr 11, 2023 | Human | Unknown | Fenbendazol Granules | Unwell; Decreased heart rate | Ongoing |
| Apr 10, 2023 | Human | Unknown | Tylosin | Skin sore; Expired drug administered; Accidental exposure; Localised pain NOS... | Outcome Unknown |
| Apr 10, 2023 | Human | Unknown | Copper Naphthenate | Eye irritation; Eye redness; Accidental exposure | Outcome Unknown |
| Apr 10, 2023 | Human | Unknown | Oclacitinib Maleate | Sinus headache; Sinus pain | Outcome Unknown |
| Apr 10, 2023 | Human | Unknown | Selamectin;Sarolaner | Caps, Abnormal; Tubes, Leaking; No sign | Recovered/Normal |
| Apr 8, 2023 | Human | Unknown | Altrenogest Oily Solution | Angina pectoris; Accidental exposure; Wrong technique in drug usage process | Ongoing |
| Apr 7, 2023 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Dizziness; Application site stickiness; Closure, Abnormal; Containers, Leakin... | Ongoing |
| Apr 7, 2023 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness | Recovered/Normal |
| Apr 6, 2023 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Itchy skin; Rash; Reddening of the skin; Discomfort NOS | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.